KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Return on Equity (2016 - 2025)

Historic Return on Equity for Pacira BioSciences (PCRX) over the last 15 years, with Q3 2025 value amounting to 0.03%.

  • Pacira BioSciences' Return on Equity rose 1400.0% to 0.03% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03%, marking a year-over-year increase of 1400.0%. This contributed to the annual value of 0.12% for FY2024, which is 1700.0% down from last year.
  • As of Q3 2025, Pacira BioSciences' Return on Equity stood at 0.03%, which was up 1400.0% from 0.16% recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Return on Equity peaked at 0.26% during Q2 2021, and registered a low of 0.16% during Q2 2025.
  • Over the past 5 years, Pacira BioSciences' median Return on Equity value was 0.03% (recorded in 2025), while the average stood at 0.03%.
  • Its Return on Equity has fluctuated over the past 5 years, first soared by 2900bps in 2021, then tumbled by -2400bps in 2025.
  • Quarter analysis of 5 years shows Pacira BioSciences' Return on Equity stood at 0.06% in 2021, then plummeted by -64bps to 0.02% in 2022, then surged by 139bps to 0.05% in 2023, then crashed by -364bps to 0.13% in 2024, then surged by 122bps to 0.03% in 2025.
  • Its Return on Equity was 0.03% in Q3 2025, compared to 0.16% in Q2 2025 and 0.13% in Q1 2025.